Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT02495974. IPD Sharing: NO. Countries: 16. Publications: 0.
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01913015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI
ClinicalTrials.gov study NCT06277674. IPD Sharing: NO. Countries: 1. Publications: 0.
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
ClinicalTrials.gov study NCT00026663. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
ClinicalTrials.gov study NCT06136598. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
ClinicalTrials.gov study NCT04104893. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT01649635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study
ClinicalTrials.gov study NCT04579484. IPD Sharing: NO. Countries: 1. Publications: 0.
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05225363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02123758. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT04918186. IPD Sharing: NO. Countries: 2. Publications: 0.
Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00058539. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT06236139. IPD Sharing: NO. Countries: 1. Publications: 0.
18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02121600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT02169063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
ClinicalTrials.gov study NCT01469338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT03490838. IPD Sharing: NO. Countries: 2. Publications: 0.
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT02380274. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT00684970. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression
GEO Series GSE135997. Mus musculus; Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.